{
  "title": "Paper_156",
  "abstract": "pmc JAMA Netw Open JAMA Netw Open 3211 jamasd JAMA Network Open 2574-3805 pmc-is-collection-domain yes pmc-collection-title JAMA Network PMC12495501 PMC12495501.1 12495501 12495501 41042514 10.1001/jamanetworkopen.2025.33512 zoi250944 1 Research Original Investigation Online Only Infectious Diseases Use of AI in Identification of Sexually Transmitted Infections and Anogenital Dermatoses A Systematic Review and Meta-Analysis Use of AI to Identify Sexually Transmitted Infections and Anogenital Dermatoses Use of AI to Identify Sexually Transmitted Infections and Anogenital Dermatoses Soe Nyi Nyi MPH  1  2 Kusnandar Ingsun Isika BBiomed  3 Latt Phyu Mon MPH  1  2 Fairley Christopher K. PhD  1  2 Chow Eric P.F. PhD  1  2  4 Maatouk Ismael PhD  5 Johnson Cheryl C. PhD  5 Shah Purvi PhD  5  6 Peters Remco P.H. PhD  5 Subissi Lorenzo PhD  7 Zhang Lei PhD  1  2  8  9 Ong Jason J. PhD  1  2  10 1 2 3 4 5 6 7 8 9 10 Article Information Accepted for Publication: Published: 10.1001/jamanetworkopen.2025.33512 Open Access: CC-BY License JAMA Network Open Corresponding Authors: drnyinyisoe1989@gmail.com jason.ong@monash.edu Author Contributions: Concept and design: Acquisition, analysis, or interpretation of data: Drafting of the manuscript: Critical review of the manuscript for important intellectual content: Statistical analysis: Obtained funding: Administrative, technical, or material support: Supervision: Conflict of Interest Disclosures: Funding/Support: Role of the Funder/Sponsor: Data Sharing Statement: Supplement 2 Additional Contributions: 3 10 2025 10 2025 8 10 498316 e2533512 21 5 2025 27 7 2025 03 10 2025 05 10 2025 05 10 2025 Copyright 2025 Soe NN et al. JAMA Network Open https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the CC-BY License. jamanetwopen-e2533512.pdf This systematic review and meta-analysis investigates the performance of artificial intelligence (AI) algorithms in detecting sexually transmitted infections and anogenital dermatoses from clinical images. Key Points Question What is the diagnostic performance of artificial intelligence (AI) in identifying sexually transmitted infections (STIs) and anogenital dermatoses from clinical images? Findings In this systematic review and meta-analysis of 140 studies, research was dominated by mpox, while other STIs such as syphilis were understudied. AI showed high performance for identifying mpox, herpes simplex, genital warts, psoriasis, and scabies, but these findings were limited by high risk of bias and a lack of clinical validation. Meaning The findings suggest that AI shows promise for identifying STIs and anogenital conditions, but research gaps in data quality, validation, and focus on clinically relevant STIs must be addressed to translate these tools into practice. Importance Artificial intelligence (AI) excels in dermatology. However, its applications to sexually transmitted infections (STIs) remain unclear. Objective To assess the performance of AI algorithms and their applications in detecting STIs and anogenital dermatoses from clinical images in sexual health. Data Sources Six databases (IEEE Xplore, Embase, Scopus, Medline, Web of Science, and CINAHL) were searched for studies published from January 1, 2010, to April 12, 2024, using 3 main concepts: artificial intelligence diagnosis sexually transmitted infections Study Selection Studies that used AI to identify anogenital skin conditions from clinical images were included. Studies that used non-AI approaches or nonanogenital conditions, as well as reviews and studies lacking performance metrics, were excluded. Data Extraction and Synthesis Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, 2 reviewers independently assessed full-text articles and extracted data using a standardized spreadsheet. Another 2 reviewers resolved any disagreements. A modified Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) critical appraisal tool and the Checklist for Evaluation of Image-Based AI Reports in Dermatology (CLEAR Derm) were used for quality assessment. Main Outcomes and Measures Pooled sensitivity and specificity of AI applications for detecting anogenital skin conditions. A bivariate random-effects meta-analysis was conducted for conditions with more than 3 studies. Results Of 5381 studies screened and 258 full texts selected, 140 met the inclusion criteria. Most studies reported on mpox (110 [78.6%]), while other anogenital conditions, including genital herpes (7 [5.0%]), genital warts (8 [5.7%]), scabies (8 [5.7%]), and molluscum contagiosum (6 [4.3%]), received less attention. Meta-analyses showed high performance of AI for identification of mpox (pooled sensitivity: 0.96 [95% CI, 0.93-0.97]; pooled specificity: 0.98 [95% CI, 0.97-0.99]), herpes simplex (sensitivity: 0.91 [95% CI, 0.71-0.98]; specificity: 0.97 [95% CI, 0.94-0.98]), genital warts (sensitivity: 0.87 [95% CI, 0.67-0.96]; specificity: 0.98 [95% CI, 0.95-0.99]), psoriasis (sensitivity: 0.90 [95% CI, 0.78-0.95]; specificity: 0.98 [95% CI, 0.96-0.99]), and scabies (sensitivity: 0.89 [95% CI, 0.84-0.93]; specificity: 0.98 [95% CI, 0.95-0.99]). Study quality was variable, and the assessment identified high risk of bias across the population selection (76.1%), reference standards (76.1%), and index tests (20.0%). Most studies relied on open-source datasets (121 [86.4%]); only 17 (12.1%) used external validation. All but 1 study (0.7%) remained at the proof-of-concept stage, and models were not publicly available for external evaluation. Conclusions and Relevance The findings suggest that AI shows promise in identifying STIs and anogenital dermatoses but that significant research gaps exist. Future work should prioritize understudied STIs and differential conditions while improving data quality, conducting external validation, and validating findings in clinical settings. pmc-status-qastatus 0 pmc-status-live yes pmc-status-embargo no pmc-status-released yes pmc-prop-open-access yes pmc-prop-olf no pmc-prop-manuscript no pmc-prop-legally-suppressed no pmc-prop-has-pdf no pmc-prop-has-supplement yes pmc-prop-pdf-only no pmc-prop-suppress-copyright no pmc-prop-is-real-version no pmc-prop-is-scanned-article no pmc-prop-preprint no pmc-prop-in-epmc yes Introduction Sexually transmitted infections (STIs) profoundly affect sexual and reproductive health worldwide. 1 2 3 4 5 STIs can be asymptomatic or present with diverse clinical manifestations. 6 7 8 9 10 7 11 12 13 Methods Study Design and Protocol We conducted this systematic review and meta-analysis following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses ( PRISMA 14 PROSPERO 15 Search Strategy and Selection Criteria We searched 6 databases (IEEE Xplore, Embase, Scopus, Medline, Web of Science, and CINAHL) for studies published from January 1, 2010, to April 12, 2024, using 3 main concepts: artificial intelligence diagnosis sexually transmitted infections Supplement 1 16 Data Extraction Two reviewers (N.N.S., I.I.K.) independently assessed full-text articles and extracted data using a standardized Microsoft Excel, version 16.100, spreadsheet (Microsoft Corporation). P.M.L. and J.J.O. resolved any disagreements in data extraction through discussion. We collected data on the following aspects: (1) study characteristics, including authors, publication year, and study type; (2) data characteristics, such as the image database, types of data input and predictions, reference conditions, and sample size; (3) technical information, including model development, evaluation methods, subgroup analyses, model interpretability, and the best-performing algorithms; and (4) performance metrics, such as area under the receiver operating characteristic curve (AUROC), accuracy, sensitivity, specificity, precision, F1 scores, and values from confusion matrices. We selected performance metrics from the best-performing model for studies reporting multiple models. We extracted true positives, false positives, true negatives, and false negatives directly from 2 × 2 tables for binary outcome studies. We recalculated these values from the tables, focusing on our target disease conditions in the studies with multiclass classifications. Quality Assessment We used a modified Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) critical appraisal tool 17 18 Statistical Analysis We conducted a descriptive analysis of study characteristics and model performance. One study 19 20 I 2 F P 21 Results From 6035 initial studies, we screened 5381 titles and abstracts and selected 258 full texts. After removing irrelevant studies, duplicates, and review articles, 140 studies met the inclusion criteria ( Figure 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 Figure. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Flow Diagram of the Study Selection Process Quality Assessment Using the modified QUADAS-2 tool, we identified a high level of bias in most studies regarding 3 domains: populations (76.1%), reference standard tests (76.1%), and index tests (20.0%). We also identified a high concern for applicability: populations (82.2%), index tests (80.7%), and reference standard tests (76.1%). The CLEAR Derm checklist showed inadequate reporting across all domains (eFigure 1 and eTable 3 in Supplement 1 Disease Conditions Most studies (110 [78.6%]) focused on mpox following the 2022 outbreak. 19 25 29 30 33 35 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 22 23 24 28 37 149 150 151 22 23 26 32 34 37 42 43 31 37 40 125 150 154 155 156 23 24 36 149 157 158 159 160 22 23 26 34 150 152 156 22 32 37 38 39 40 41 23 24 26 37 152 153 22 23 26 37 125 149 44 46 47 48 26 Supplement 1 25 29 33 35 44 45 46 47 48 49 50 51 52 53 55 56 57 58 59 60 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 115 116 117 118 119 120 121 122 123 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 22 23 24 26 27 28 32 37 40 65 72 124 125 149 150 155 156 158 50 51 52 53 54 55 Data Most studies used open-source data (121 [86.4%] 22 24 29 35 39 42 43 44 45 46 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 68 69 70 71 72 73 74 75 76 77 79 80 81 82 83 84 85 88 89 91 92 93 94 95 96 97 99 100 101 102 103 104 105 106 108 109 110 111 112 113 115 116 117 118 120 121 123 124 125 126 127 128 129 130 131 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 151 153 154 156 157 159 160 23 26 27 28 31 32 34 37 38 150 155 158 25 30 33 36 90 Supplement 1 18 23 24 25 29 30 33 35 36 39 41 42 43 44 45 46 47 48 49 50 51 52 53 54 56 57 58 59 60 61 62 64 66 67 68 69 70 71 72 73 74 75 76 77 79 80 81 82 83 84 90 91 92 94 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 122 123 124 125 126 128 129 130 131 134 135 136 137 138 139 142 143 144 146 147 148 151 154 156 157 160 161 162 163 Supplement 1 24 23 37 34 30 39 159 Most datasets that were used contained clinical images alone; datasets of only 8 studies (5.7%) contained additional patient metadata (sex, race, ethnicity, symptoms, etc). 52 54 55 59 60 61 62 63 33 52 54 59 61 62 64 65 22 24 25 26 27 30 31 36 37 43 72 86 106 150 159 23 24 25 26 27 28 30 31 32 34 37 55 90 101 142 158 159 International Classification of Diseases, Ninth Revision (ICD-9) International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10) 52 54 59 Model Development Over half of the studies (78 [55.7%]) focused on developing binary classification models, 23 25 27 33 34 35 36 44 45 46 47 48 49 50 52 53 54 56 59 60 61 64 65 66 68 69 74 75 77 79 80 85 88 89 91 92 93 95 97 99 100 102 104 105 106 108 111 112 115 117 118 120 123 124 127 128 129 130 134 135 140 141 144 145 148 152 155 157 159 160 22 24 26 28 29 30 31 32 37 38 40 41 42 43 51 55 58 62 63 68 70 71 72 73 76 81 82 83 84 88 90 94 96 101 103 113 115 116 121 125 126 136 137 138 139 142 143 146 147 149 150 151 153 154 156 158 55 59 26 37 54 65 66 74 85 87 97 102 114 135 138 141 144 145 156 Model Evaluation All but 14 studies (10.0%) reported fully or partially splitting their data into training and testing sets, 26 37 39 70 84 95 121 124 127 130 146 148 149 159 k 23 25 27 30 33 45 53 55 57 61 62 68 72 75 80 81 83 89 90 97 100 102 105 106 108 110 117 123 136 139 142 150 152 155 158 23 24 25 26 28 30 37 84 59 61 66 24 27 28 30 32 37 28 24 28 30 33 34 24 26 27 28 30 24 27 28 30 28 30 24 25 28 30 32 33 46 47 48 59 60 62 67 68 72 79 96 106 113 114 115 123 125 136 Model Performance We summarized model performance metrics by target condition ( Table 1 22 41 23 25 28 29 30 31 33 35 37 39 41 44 45 46 47 48 49 51 52 53 55 56 62 64 65 66 67 68 69 71 72 73 74 75 76 78 79 80 83 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 106 107 109 110 111 114 115 116 117 119 120 121 122 124 125 126 127 128 129 130 131 132 133 134 135 136 137 139 140 141 142 144 145 147 148 151 153 154 156 158 159 160 27 32 36 40 43 50 57 59 60 61 63 70 77 81 82 84 85 91 96 102 105 108 110 113 118 123 138 143 146 Table 1. Summary of Model Performance Across Disease Conditions Disease condition Sensitivity Specificity PPV NPV AUROC Accuracy F1 score Syphilis (chancre, condylomata lata) (n = 1) Metric, mean (SD) 0.87 (NA) 0.99 (NA) 0.91 (NA) NA NA 0.94 (NA) 0.95 (NA) Studies, No. 1 1 1 1 1 1 1 Herpes simplex (n = 7) Metric Mean (SD) 0.58 (0.45) 0.98 (0.02) 0.63 (0.46) NA 1.00 (NA) 0.74 (0.30) 0.66 (0.48) Median (IQR) 0.62 (0.20-0.96) 0.98 (0.97-0.99) 0.87 (0.10-0.93) NA NA 0.84 (0.69-0.94) 0.92 (0.10-0.96) Range 0.10-0.99 0.97-0.99 0.10-0.93 NA NA 0.10-0.97 0.10-0.96 Studies, No. 4 2 3 0 1 7 3 Genital warts (n = 8) Metric Mean (SD) 0.82 (0.20) 0.99 (0.02) 0.69 (0.37) 1.00 (NA) 0.85 (NA) 0.86 (0.15) 0.96 (0.05) Median (IQR) 0.93 (0.57-0.96) 1.00 (0.96-1.00) 0.86 (0.57-0.94) NA NA 0.94 (0.69-0.97) 0.97 (0.91-1.00) Range 0.56-1.00 0.96-1.00 0.10-1.00 NA NA 0.65-0.98 0.91-1.00 Studies, No. 6 3 5 1 1 6 3 Mpox (n = 110) Metric Mean (SD) 0.92 (0.09) 0.93 (0.09) 0.93 (0.06) 0.94 (0.09) 0.96 (0.06) 0.93 (0.06) 0.92 (0.08) Median (IQR) 0.94 (0.88-1.00) 0.97 (0.90-0.99) 0.95 (0.91-1.00) 0.98 (0.93-0.99) 0.98 (0.94-1.00) 0.95 (0.91-1.00) 0.94 (0.90-1.00) Range 0.58-1.00 0.61-1.00 0.70-1.00 0.79-1.00 0.74-1.00 0.74-1.00 0.67-1.00 Models, No. 114 37 102 5 37 127 107 Tinea cruris (n = 8) Metric Mean (SD) 0.53 (0.39) 0.99 (0.01) 0.28 (0.25) 1.00 (NA) 0.98 (NA) 0.62 (0.36) 0.52 (0.60) Median (IQR) 0.64 (0.10-0.85) 0.99 (0.99-1.00) 0.28 (0.10-0.45) NA NA 0.72 (0.40-0.84) 0.52 (0.10-0.94) Range 0.10-0.85 0.99-1.00 0.10-0.45 NA NA 0.10-0.92 0.10-0.94 Studies, No. 3 2 2 1 1 4 2 Molluscum contagiosum (n = 6) Metric Mean (SD) 0.55 (0.38) 0.98 (0.02) 0.59 (0.43) 0.98 (NA) 0.95 (NA) 0.53 (0.35) 0.51 (0.58) Median (IQR) 0.55 (0.23-0.92) 0.98 (0.97-0.99) 0.76 (0.10-0.92) NA NA 0.55 (0.25-0.80) 0.51 (0.10-0.92) Range 0.10-0.93 0.97-0.99 0.10-0.92 NA NA 0.10-0.92 0.10-0.92 Studies, No. 6 2 3 1 1 4 2 Lichenoid changes (n = 6) Metric Mean (SD) 0.59 (0.30) 0.97 (0.01) 0.71 (0.26) 0.99 (NA) 0.88 (NA) 0.65 (0.25) 0.83 (0.24) Median (IQR) 0.57 (0.56-0.68) 0.97 (0.97-0.98) 0.64 (0.49-1.00) NA NA 0.69 (0.53-0.73) 0.83 (0.66-1.00) Range 0.16-1.00 0.97-0.98 NA NA NA 0.31-0.99 0.66-1.00 Studies, No. 5 2 3 1 1 5 2 Scabies (n = 8) Metric Mean (SD) 0.83 (0.16) 1.00 0.89 (0.13) NA NA 0.85 (0.10) NA Median (IQR) 0.86 (0.71-0.95) NA 0.89 (0.80-0.98) NA NA 0.85 (0.77-0.92) NA Range 0.63-0.98 NA 0.80-0.98 NA NA 0.69-0.99 NA Studies, No. 4 1 2 0 0 7 0 Folliculitis (n = 3) Metric Mean (SD) 0.36 (0.35) NA NA NA NA 0.42 (0.24) NA Median (IQR) 0.36 (0.11-0.60) NA NA NA NA 0.55 (0.14-0.57) NA Range 0.11-0.60 NA NA NA NA 0.14-0.57 NA Studies, No. 2 0 0 0 0 3 0 Herpes zoster (n = 8) Metric Mean (SD) 0.82 (0.13) 0.98 (0.03) 0.85 (0.19) 1.00 (NA) 0.94 (0.05) 0.94 (0.03) 0.95 (0.04) Median (IQR) 0.83 (0.71-0.91) 1.00 (0.94-1.00) 0.93 (0.74-0.96) NA 0.93 (0.89-0.99) 0.95 (0.92-0.96) 0.95 (0.92-0.99) Range 0.67-0.96 0.94-1.00 0.57-0.97 NA 0.89-0.99 0.90-0.97 0.92-0.99 Studies, No. 5 3 4 1 3 5 3 Psoriasis (n = 7) Metric Mean (SD) 0.72 (0.35) 0.96 (NA) 0.65 (0.40) 0.98 (NA) 0.93 (NA) 0.58 (0.41) 0.55 (0.64) Median (IQR) 0.84 (0.78-1.00) NA 0.75 (0.36-1.00) NA NA 0.62 (0.25-0.92) 0.55 (0.10-1.00) Range 0.10-1.00 NA 0.10-1.00 NA NA 0.10-0.99 0.10-1.00 Studies, No. 5 1 4 1 1 4 2 Candidiasis (n = 1) Metric, mean (SD) 0.41 (NA) 1.00 (NA) 0.41 (NA) 1.00 (NA) 0.81 (NA) NA NA Studies, No. 1 1 1 1 1 0 0 Balanitis (n = 2) Metric Mean (SD) 0.88 (NA) 1.00 (NA) 0.97 (NA) NA NA 0.64 (0.43) 0.98 (NA) Median (IQR) NA NA NA NA NA 0.64 (0.33-0.94) NA Range NA NA NA NA NA 0.33-0.94 NA Studies, No. 1 1 1 0 0 2 1 Penile cancer (n = 1) Metric, mean (SD) 0.79 (NA) 0.99 (NA) 0.89 (NA) NA NA 0.94 (NA) 0.93 (NA) Studies, No. 1 1 1 0 0 1 1 STIs (n = 1) Metric, mean (SD) 0.95 (NA) 0.62 (NA) 0.43 (NA) NA 0.89 (NA) 0.69 (NA) NA Studies, No. 1 1 1 0 1 1 1 Abbreviations: AUROC, area under the receiver operating characteristic curve; NA, not applicable; NPV, negative predictive value; PPV, positive predictive value; STI, sexually transmitted infection. Application All of the studies but 1 (0.7%) 26 26 Meta-Analysis For meta-analysis, we included 47 studies: 31 mpox studies (66.0%; 34 contingency tables) 25 30 35 68 72 83 88 90 96 97 105 106 110 111 113 115 116 117 123 125 126 129 136 143 144 38 39 40 41 23 32 34 43 23 34 150 156 40 125 150 156 Figure I 2 I 2 I 2 I 2 I 2 I 2 I 2 I 2 I 2 I 2 Supplement 1 We conducted subgroup analyses and meta-regression for heterogeneity only for mpox studies, as there were limited studies and insufficient data to perform subgroup analysis for other conditions ( Table 2 P P Table 3 6 18 27 28 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 Table 2. Summary Estimates of Pooled Performance of AI Models for Mpox Characteristic Models, No. (%) Model F 4,29 P Model F 4,29 P Sensitivity P a I 2 b P c Specificity P a I 2 b P c Overall 34 (100) 0.96 (0.93-0.97) <.001 90.98 (88.74-93.22) NA 0.98 (0.97-0.99) <.001 99.90 (99.90-99.91) NA Lesion types included, No. <5 26 (76.5) 0.96 (0.93-0.98) <.001 89.86 (86.87-92.85) .13 0.98 (0.97-0.99) <.001 92.84 (90.93-94.74) .96 ≥5 8 (23.5) 0.93 (0.84-0.97) <.001 93.47 (90.31-96.64) 0.97 (0.95-0.99) <.001 99.95 (99.95-99.96) Sample size <1000 23 (67.6) 0.95 (0.91-0.97) <.001 88.49 (84.74-92.24) .049 0.98 (0.97-0.99) <.001 91.29 (88.67-93.91) .53 ≥1000 11 (32.4) 0.97 (0.92-0.99) <.001 94.07 (91.73-96.42) 0.97 (0.95-0.99) <.001 99.96 (99.96-99.97) Model classification Binary 17 (50.0) 0.97 (0.95-0.99) <.001 87.87 (83.16-92.57) .03 0.98 (0.95-0.99) <.001 92.43 (89.87-94.98) .20 Multiclass 17 (50.0) 0.93 (0.88-0.96) <.001 89.02 (84.89-93.15) 0.98 (0.97-0.99) <.001 99.95 (99.95-99.95) AI algorithm CNN based 26 (76.5) 0.95 (0.92-0.97) <.001 91.31 (88.86-93.76) .54 0.98 (0.96-0.99) <.001 99.91 (99.91-99.92) .40 Other 8 (23.5) 0.95 (0.89-0.98) <.001 88.42 (81.81-95.04) 0.98 (0.97-0.99) .050 50.25 (10.19-90.31) Abbreviations: AI, artificial intelligence; CNN, convolutional neural network.  a P  b Higgins I 2  c P Table 3. Summary of Research Gaps and Future Recommendations for AI-Based Identification of STIs and Anogenital Dermatoses Research gap or limitation Recommendations  1. Disease conditions 1.1 Imbalanced research focus: Studies predominantly focused on mpox (78.6%) due to the recent outbreak, while common STIs and anogenital conditions received limited attention (<6.0% each) Balanced research agenda: Prioritize AI research into common STIs and anogenital conditions while continuing to investigate emerging outbreaks like mpox, with an emphasis on WHO-priority infections such as syphilis, genital herpes, and genital warts 1.2 Limited differential coverage: Studies lacked clinically relevant comparative conditions and comprehensive coverage of anogenital conditions as seen in sexual health clinical practice Diverse and representative data: Include a wide variety of anogenital reference conditions covering STIs, non-STIs, tumors, inflammatory diseases, and normal anatomic variants for robust differential diagnosis 6 164 165 166 1.3 Poor disease standardization: Lack of standardized disease definition undermined clinical relevance and hindered reproducibility (eg, herpes simplex vs herpes zoster; genital warts vs flat warts) Adoption of ICD-10 ICD-10 18  2. Data 2.1 Data scarcity challenges: Models relied heavily on open-source datasets (86.5%), with small sample sizes, limited representation of target conditions, and absence of patient metadata 167 Coordinated data infrastructure: Establish networks for standardized image collection and develop a centralized repository (similar to the IARC Cervical Cancer Image Bank 168 2.2 Data quality concern: Duplicate images across public datasets compromised data quality 169 170 Implementation of deduplication processes: Use systematic methods or tools to identify and remove duplicate images to ensure data quality Transparent reporting: Document and transparently report all methods for image quality control 171 2.3 Inadequate technical documentation: Most studies (89.4%) lacked essential details regarding image acquisition methods and quality standards Technical standardization: Adopt and adapt established technical guidelines to ensure consistent quality in clinical image acquisition 172 Documentation and reporting for reproducibility: Provide detailed documentation of image acquisition methods, quality standards, and technical specifications 172 2.4 Insufficient diagnostic validation: Limited validation of image diagnoses through laboratory tests or clinical reviews undermined data reliability Diagnostic validation standards: Require validation of image diagnoses through laboratory confirmation and/or expert clinical review before inclusion in datasets 6  3. Model development 3.1 Unclear clinical alignment: Model development lacked clear alignment with intended clinical applications Purpose-driven development: Define clear clinical objectives (rule in or rule out) and model approach (binary or multiclass) based on intended clinical use (screening, triage, or assisted diagnosis) 173 Interdisciplinary collaboration: Ensure development teams include data scientists, AI experts, sexual health physicians, and end users 173 174 3.2 Inadequate reporting of methods: Insufficient documentation of data splitting and cross-validation approaches, including crucial stratification methods with patient metadata (sex, lesion site, skin tone, etc) and diagnoses Data splitting integrity: Prevent data leakage by ensuring images from the same patient remain in the same dataset split Stratified validation protocols: Implement stratified data splitting and cross-validation based on patient characteristics and diagnoses 3.3 Underused multimodal approach: Most models used only image data, with minimal integration of patient metadata (1.4%), despite the potential benefits of a multimodal approach 27 28 Multimodal integration: Develop models that combine clinical images with relevant patient metadata to improve diagnostic accuracy  4. Model evaluation 4.1 Limited generalizability: Model generalizability was limited by a lack of external validation and clinical trials, with most studies being single-center evaluations Model availability: Encourage public accessibility of trained models to facilitate external validation Multicenter validation: Establish collaborative networks for prospective model testing across various clinical settings 4.2 Limited subgroup assessment: Minimal evaluation across genders, skin tones, lesion sites, ages, races, and ethnicities Gender-specific models: Develop dedicated models specifically for females to address unique anatomic features and disease presentations Diverse subgroup analysis: Evaluate model performance across different demographic groups, anatomic sites, and clinical presentations 175 4.3 Unexplained model decisions: Limited reporting of model interpretability techniques (17.0%), leaving model decision processes unclear Model transparency with visualization: Implement modern interpretability techniques (eg, Grad-CAM, LIME, SHAP) to explain the model’s decision-making processes  5. Model performance 5.1 Inconsistent performance reporting: Inconsistent reporting performance metrics hindered model comparison Standardized performance reporting: Document key performance metrics (AUROC, sensitivity, specificity, PPV, and F1 scores) and contingency tables on test datasets to enable meaningful comparisons 5.2 Unclear threshold criteria: Binary classification studies lacked specified threshold selection criteria for sensitivity and specificity trade-offs based on intended use Performance trade-off reporting: Specify how sensitivity and specificity thresholds were optimized for the intended clinical application 5.3 Variable model performance: Performance varied widely due to differences in model architectures, purposes, and reference condition selections Facilitation of evidence synthesis: Conduct more studies on prioritized diseases using a standardized reporting framework to generate robust evidence, enabling meta-analysis to derive stronger conclusions on model accuracy and clinical utility  6. Application 6.1 Limited translation to practice: Studies remained at the proof-of-concept stage without defined clinical purpose (triage or screening) or target users (clinicians or public) 176 Bridging of research and practice: Encourage collaborations between researchers, health care practitioners, and policy makers to translate proof-of-concept studies into clinically viable solutions Development of an implementation framework: Establish frameworks to guide from the development stage to integration of AI models into existing health care workflows with a multidisciplinary team 173 177 6.2 Minimal clinical implementation: Only 1 public-facing application was tested prospectively, with no RCTs conducted Testing beyond conceptualization: Advance AI models from the conceptual stage by conducting pilot testing and clinical trials to generate robust evidence on their safety, efficacy, and clinical utility 178 6.3 Limited study on user’s perspective: Limited evidence on the needs, expectations, and experience of end users, such as clinicians and patients, in adopting AI models for implementation Incorporation of usability testing: Conduct feasibility, acceptability, and usability studies to ensure models meet the practical requirements of their target users in clinical or public health settings 179 180 181 Abbreviations: AI, artificial intelligence; AUROC, area under the receiver operating characteristic curve; IARC, International Agency for Research on Cancer; ICD-10 International Statistical Classification of Diseases and Related Health Problems, 10th Revision Discussion Across 6 databases, we identified 140 eligible studies that used AI to detect or classify STIs and anogenital dermatoses. Anogenital conditions like syphilis, genital herpes, and other common differential dermatoses in sexual health have received limited attention. Meta-analysis demonstrated promising performance metrics, with pooled sensitivity above 0.87 and pooled specificity above 0.97 for conditions including mpox, herpes simplex, genital warts, psoriasis, and scabies. However, the high heterogeneity ( I 2 182 18 13 Although AI in dermatology shows promise, its use for STIs and anogenital dermatoses remains limited. 13 27 32 6 164 165 166 The poor quality of data represents a fundamental barrier to the development of reliable AI, and our systematic review and meta-analysis highlighted critical challenges regarding data scarcity, quality, and validity. The heavy reliance on limited open-source datasets, the duplication of images, and, most importantly, the lack of clinical validation for image diagnoses raise concerns about the generalizability of reported model performance. Images of anogenital dermatoses are particularly scarce compared with other dermatologic conditions. 167 168 Most included studies focused on technical aspects of data processing and algorithm design yet overlooked 2 important areas. First, studies rarely defined their target users (the general public or health care practitioners) and use-case scenarios (self-symptom checking or clinical diagnosis support). Clear alignment between model design and clinical application could be achieved by a multidisciplinary team approach (data scientists, AI experts, sexual health physicians, and end users) and following the OPTICA tool. 173 172 175 Most studies remained at the conceptual stage with limited translation into clinical applications. However, this technical focus should not preclude the exploration of end-user perspectives, which are crucial for successful implementation. A few studies explored the public’s acceptability, feasibility, and preferences for the tool when it becomes available. For example, Ly et al 179 183 180 Strengths and Limitations Our review has a number of strengths. We conducted a comprehensive search across 6 databases to capture all AI applications for anogenital dermatoses. We conducted meta-analyses for 5 conditions and explored sources of heterogeneity in mpox studies through meta-regression. In addition, we provided a structured framework of research gaps and practical recommendations for future research and clinical settings. Our study also has limitations. First, despite our comprehensive search strategy, we may have missed relevant studies in nonindexed journals and commercial AI applications. Second, we modified the QUADAS-2 tool for risk of bias assessment, as it is not specifically designed for AI studies in dermatology. The modification might introduce subjective bias. Third, while we included studies based on target diagnoses relevant to sexual health, many of these AI models were developed using images from both anogenital and nonanogenital body sites. Our findings may not accurately reflect the performance of AI models specifically designed for STIs and anogenital dermatoses. Fourth, we used standard bivariate meta-analysis rather than exact methods, which may be more appropriate for sensitivity and specificity close to 1. 184 Conclusions The findings of this systematic review and meta-analysis suggest that while AI shows promising performance metrics for identifying STIs and anogenital dermatoses, significant research gaps exist. Future work should prioritize understudied STIs and differential conditions while improving data quality, conducting external validation, and validating findings in clinical settings. Clear policy guidance and standards are needed to determine how best to implement AI tools for diagnostic purposes and to provide clear performance criteria and frameworks for AI developers, health care practitioners, and clients. References 1 Centers for Disease Control and Prevention https://www.cdc.gov/sti/php/communication-resources/prevalence-incidence-and-cost-estimates.html 2 World Health Organization 2024 https://www.who.int/publications/i/item/9789240094925 3 Laurenson-Schafer H Sklenovská N Hoxha A WHO mpox Surveillance and Analytics team Description of the first global outbreak of mpox: an analysis of global surveillance data Lancet Glob Health 2023 11 7 e1012 e1023 10.1016/S2214-109X(23)00198-5 37349031 PMC10281644 4 Fairley CK Chow EPF Hocking JS Early presentation of symptomatic individuals is critical in controlling sexually transmissible infections Sex Health 2015 12 3 181 182 10.1071/SH15036 26053954 5 Centers for Disease Control and Prevention https://www.cdc.gov/sti/ 6 Ong JJ Bourne C Dean JA Australian sexually transmitted infection (STI) management guidelines for use in primary care 2022 update Sex Health 2023 20 1 1 8 10.1071/SH22134 36356948 7 Soe NN Towns JM Latt PM Accuracy of symptom checker for the diagnosis of sexually transmitted infections using machine learning and Bayesian network algorithms BMC Infect Dis 2024 24 1 1408 10.1186/s12879-024-10285-4 39695420 PMC11654068 8 He J Li J Jiang S Application of machine learning algorithms in predicting HIV infection among men who have sex with men: model development and validation Front Public Health 2022 10 967681 10.3389/fpubh.2022.967681 36091522 PMC9452878 9 Xu X Yu Z Ge Z Web-based risk prediction tool for an individual’s risk of HIV and sexually transmitted infections using machine learning algorithms: development and external validation study J Med Internet Res 2022 24 8 e37850 10.2196/37850 36006685 PMC9459839 10 Latt PM Soe NN Xu X Assessing disparity in the distribution of HIV and sexually transmitted infections in Australia: a retrospective cross-sectional study using Gini coefficients BMJ Public Health 2023 1 1 e000012 10.1136/bmjph-2023-000012 40017849 PMC11812685 11 Nieuwenburg SA Hoornenborg E Davidovich U de Vries HJC Schim van der Loeff M Developing a symptoms-based risk score for infectious syphilis among men who have sex with men Sex Transm Infect 2023 99 5 324 329 36400527 10.1136/sextrans-2022-055550 PMC10359546 12 Soe NN Latt PM Yu Z Clinical features-based machine learning models to separate sexually transmitted infections from other skin diagnoses J Infect 2024 88 4 106128 10.1016/j.jinf.2024.106128 38452934 13 Venkatesh KP Raza MM Nickel G Wang S Kvedar JC Deep learning models across the range of skin disease NPJ Digit Med 2024 7 1 32 10.1038/s41746-024-01033-8 38341516 PMC10858968 14 Page MJ McKenzie JE Bossuyt PM The PRISMA 2020 statement: an updated guideline for reporting systematic reviews BMJ 2021 372 71 n71 10.1136/bmj.n71 33782057 PMC8005924 15 Soe NN Kusnandar II Latt PM 2024 https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42024527420 16 Covidence Systematic Review Software. Veritas Health Innovation; 2024 https://www.covidence.org/ 17 Whiting PF Rutjes AWS Westwood ME QUADAS-2 Group QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies Ann Intern Med 2011 155 8 529 536 10.7326/0003-4819-155-8-201110180-00009 22007046 18 Daneshjou R Barata C Betz-Stablein B Checklist for evaluation of image-based artificial intelligence reports in dermatology: CLEAR Derm consensus guidelines from the International Skin Imaging Collaboration Artificial Intelligence Working Group JAMA Dermatol 2022 158 1 90 96 10.1001/jamadermatol.2021.4915 34851366 PMC9845064 19 Adar T Delice EK Delice O A user-friendly AI-based clinical decision support system for rapid detection of pandemic diseases: COVID-19 and monkeypox J Intell Fuzzy Syst 2024 46 2 5343 5358 10.3233/JIFS-232477 20 Retraction J Intell Fuzzy Syst 2024 47 5-6 543 578 10.3233/JIFS-219433 21 Stata. Release 18. StataCorp LLC; 2024 https://www.stata.com/ 22 Gaffoor N Soomro S 2023 10.1109/IoTaIS60147.2023.10346059 23 Pangti R Mathur J Chouhan V A machine learning-based, decision support, mobile phone application for diagnosis of common dermatological diseases J Eur Acad Dermatol Venereol 2021 35 2 536 545 10.1111/jdv.16967 32991767 24 Shen Y Li H Sun C Optimizing skin disease diagnosis: harnessing online community data with contrastive learning and clustering techniques NPJ Digit Med 2024 7 1 28 10.1038/s41746-024-01014-x 38332257 PMC10853166 25 Soe NN Yu Z Latt PM Using AI to Differentiate Mpox From Common Skin Lesions in a Sexual Health Clinic: Algorithm Development and Validation Study J Med Internet Res 2024 26 e52490 10.2196/52490 39269753 PMC11437223 26 Zaar O Larson A Polesie S Evaluation of the diagnostic accuracy of an online artificial intelligence application for skin disease diagnosis Acta Derm Venereol 2020 100 16 adv00260 10.2340/00015555-3624 32852557 PMC9234984 27 Soe NN Yu Z Latt PM Evaluation of artificial intelligence-powered screening for sexually transmitted infections-related skin lesions using clinical images and metadata BMC Med 2024 22 1 296 10.1186/s12916-024-03512-x 39020355 PMC11256573 28 Liu Y Jain A Eng C A deep learning system for differential diagnosis of skin diseases Nat Med 2020 26 6 900 908 10.1038/s41591-020-0842-3 32424212 29 Oztel I Oztel GY Sahin VH Deep learning-based skin diseases classification using smartphones Adv Intell Syst 2023 5 12 2300211 10.1002/aisy.202300211 30 Thieme AH Zheng Y Machiraju G A deep-learning algorithm to classify skin lesions from mpox virus infection Nat Med 2023 29 3 738 747 10.1038/s41591-023-02225-7 36864252 PMC10033450 31 Yotsu RR Ding Z Hamm J Blanton RE Deep learning for AI-based diagnosis of skin-related neglected tropical diseases: a pilot study PLoS Negl Trop Dis 2023 17 8 e0011230 10.1371/journal.pntd.0011230 37578966 PMC10449179 32 Allan-Blitz LT Ambepitiya S Tirupathi R Klausner JD The development and performance of a machine-learning based mobile platform for visually determining the etiology of 5 penile diseases Mayo Clin Proc Digit Health 2024 2 2 280 288 10.1016/j.mcpdig.2024.04.006 40207173 PMC11975829 33 Campana MG Colussi M Delmastro F Mascetti S Pagani E A transfer learning and explainable solution to detect mpox from smartphones images Pervasive Mobile Comput 2024 98 101874 10.1016/j.pmcj.2023.101874 34 Casuayan De Goma J Devaraj M 2020 10.1145/3418688.3418700 35 Thorat R Gupta A Transfer learning-enabled skin disease classification: the case of monkeypox detection Multimed Tools Appl 2024 10.1007/s11042-024-18750-7 36 Back S Lee S Shin S Robust skin disease classification by distilling deep neural network ensemble for the mobile diagnosis of herpes zoster IEEE Access 2021 9 20156 20169 10.1109/ACCESS.2021.3054403 37 Mehta N Khan E Choudhary R Dholakia D Goel S Gupta S The performance of an artificial intelligence-based computer vision mobile application for the image diagnosis of genital dermatoses: a prospective cross-sectional study Int J Dermatol 2024 63 8 1074 1080 10.1111/ijd.17060 38314623 38 Wei LS Gan Q Ji T Skin disease recognition method based on image color and texture features Comput Math Methods Med 2018 2018 8145713 10.1155/2018/8145713 30224935 PMC6129338 39 Yadav A Sharma V Seth J 2023 40 Akmalia N Sihombing P 2019 https://ieeexplore.ieee.org/xpl/conhome/8933309/proceeding 41 Sadik R Majumder A Biswas AA Ahammad B Rahman MM An in-depth analysis of convolutional neural network architectures with transfer learning for skin disease diagnosis Healthc Anal (N Y) 2023 3 100143 10.1016/j.health.2023.100143 42 Nosseir A Shawky MA Proceedings of the 2019 8th International Conference on Software and Information Engineering 2019 10.1145/3328833.3328862 43 Dodia D Jakharia H Soni R Borade S Jain N 2022 https://ceur-ws.org/Vol-3338/ 44 Abdelhamid AA El-Kenawy ESM Khodadadi N Classification of monkeypox images based on transfer learning and the Al-Biruni Earth radius optimization algorithm Mathematics 2022 10 19 3614 10.3390/math10193614 45 Agrawal S Castelino K Mehta J Bhavathankar P 2022 10.1109/SMARTGENCON56628.2022.10083786 46 Ahsan MM Alam TE Haque MA Enhancing monkeypox diagnosis and explanation through modified transfer learning, vision transformers, and federated learning Inform Med Unlocked 2024 45 101449 10.1016/j.imu.2024.101449 47 Ahsan MM Ali MS Hassan MM Monkeypox diagnosis with interpretable deep learning IEEE Access 2023 11 81965 81980 10.1109/ACCESS.2023.3300793 48 Ahsan MM Uddin MR Ali MS Deep transfer learning approaches for Monkeypox disease diagnosis Expert Syst Appl 2023 216 119483 10.1016/j.eswa.2022.119483 36624785 PMC9814470 49 Alcalá-Rmz V Villagrana-Bañuelos KE Celaya-Padilla JM Galván-Tejada JI Gamboa-Rosales H Galván-Tejada CE Proceedings of the International Conference on Ubiquitous Computing & Ambient Intelligence (UCAmI 2022). 2023 Lecture Notes in Networks and Systems 10.1007/978-3-031-21333-5_9 50 Alharbi AH Towfek SK Abdelhamid AA Diagnosis of monkeypox disease using transfer learning and binary advanced dipper throated optimization algorithm Biomimetics (Basel) 2023 8 3 313 10.3390/biomimetics8030313 37504202 PMC10807651 51 Alhasson HF Almozainy E Alharbi M Almansour N Alharbi SS Khan RU A deep learning-based mobile application for monkeypox detection Appl Sci (Basel) 2023 13 23 12589 10.3390/app132312589 52 Almufareh MF Tehsin S Humayun M Kausar S A transfer learning approach for clinical detection support of monkeypox skin lesions Diagnostics (Basel) 2023 13 8 1503 10.3390/diagnostics13081503 37189603 PMC10137438 53 Almutairi SA DL-MDF-OH 2 Electronics (Basel) 2022 11 24 4077 10.3390/electronics11244077 54 Aloraini M An effective human monkeypox classification using vision transformer Int J Imaging Syst Technol 2024 34 1 10.1002/ima.22944 55 Alrusaini OA Deep learning models for the detection of monkeypox skin lesion on digital skin images Int J Adv Comput Sci Appl 2023 14 1 637 644 10.14569/IJACSA.2023.0140170 56 Altun M Gürüler H Özkaraca O Khan F Khan J Lee Y Monkeypox detection using CNN with transfer learning Sensors (Basel) 2023 23 4 1783 10.3390/s23041783 36850381 PMC9964526 57 Amin J Gul N Naqvi SA Proceedings of the 2023 29th International Conference on Information, Communication and Automation Technologies (ICAT 2023 10.1109/ICAT57854.2023.10171265 58 Arshed MA Rehman HA Ahmed S Dewi C Christanto HJA 16 x 16 patch-based deep learning model for the early prognosis of monkeypox from skin color images Computation (Basel) 2024 12 2 33 10.3390/computation12020033 59 Asif S Zhao M Li Y Tang F Zhu Y CGO-ensemble: Chaos game optimization algorithm-based fusion of deep neural networks for accurate Mpox detection Neural Netw 2024 173 106183 10.1016/j.neunet.2024.106183 38382397 60 Asif S Zhao M Tang F Zhu Y Zhao B Metaheuristics optimization-based ensemble of deep neural networks for Mpox disease detection Neural Netw 2023 167 342 359 10.1016/j.neunet.2023.08.035 37673024 61 Attallah O MonDiaL-CAD: Monkeypox diagnosis via selected hybrid CNNs unified with feature selection and ensemble learning Digit Health 2023 9 20552076231180054 10.1177/20552076231180054 37312961 PMC10259124 62 Bala D Hossain MS Hossain MA MonkeyNet: a robust deep convolutional neural network for monkeypox disease detection and classification Neural Netw 2023 161 757 775 10.1016/j.neunet.2023.02.022 36848828 PMC9943560 63 Bansal M Arora R Keshari S Panchal S Proceedings of the International Conference on Lecture Notes in Networks and Systems 2023 10.1007/978-981-99-6550-2_3 64 Bogar SM Deshmukh P Reddy CVR Muvva S Proceedings of the 2023 2nd International Conference on Augmented Intelligence and Sustainable Systems, ICAISS 2023 2023 10.1109/ICAISS58487.2023.10250644 65 Chandrahaas BV Mohanty SN Panda SK Michael G An empirical study on classification of monkeypox skin lesion detection EAI Endorsed Trans Pervasive Health Technol 2023 9 1 e4 10.4108/eetpht.v8i5.3352 66 Chauhan N Bala A 2023 https://www.proceedings.com/content/072/072369webtoc.pdf 67 Chen B Han Y Yan L A Few-shot learning approach for Monkeypox recognition from a cross-domain perspective J Biomed Inform 2023 144 104449 10.1016/j.jbi.2023.104449 37488025 68 Chen J Han J A study on the recognition of monkeypox infection based on deep convolutional neural networks Front Immunol 2023 14 101560960 1225557 10.3389/fimmu.2023.1225557 38130718 PMC10733491 69 Chintamaneni V Krishna BH Suresh M Deep learning-based diagnostic model for automated detection of monkeypox: introducing MonkeypoxNet TS Trait Signal 2024 41 1 493 502 10.18280/ts.410144 70 Ciran A Ozbay E 2023 https://ieeexplore.ieee.org/document/10304930 71 Dahiya N Sharma YK Rani U Hyper-parameter tuned deep learning approach for effective human monkeypox disease detection Sci Rep 2023 13 1 15930 10.1038/s41598-023-43236-1 37741892 PMC10517970 72 Dan R Wu Q Ji X LSANet: lesion-specific attention network for monkeypox categorization Proceedings—2022 IEEE SmartWorld, Ubiquitous Intelligence and Computing, Autonomous and Trusted Vehicles, Scalable Computing and Communications, Digital Twin, Privacy Computing, Metaverse IEEE 2022 210 217 10.1109/SmartWorld-UIC-ATC-ScalCom-DigitalTwin-PriComp-Metaverse56740.2022.00054 73 Dwivedi M Tiwari RG Ujjwal N 2022 https://ieeexplore.ieee.org/document/10009140 74 Eliwa EHI El Koshiry AM Abd El-Hafeez T Farghaly HM Utilizing convolutional neural networks to classify monkeypox skin lesions Sci Rep 2023 13 1 14495 10.1038/s41598-023-41545-z 37661211 PMC10475460 75 Ezenkwu CP Stephen BUA Affiah I Daniel B 2023 https://ieeexplore.ieee.org/xpl/conhome/10293181/proceeding 76 Fisranda F Austin F Sadrawi M Proceedings of the 2023 5th International Conference on Cybernetics and Intelligent Systems (ICORIS 2023) 2023 10.1109/ICORIS60118.2023.10352306 77 Gairola AK Kumar V Proceedings of the 2022 8th International Conference on Signal Processing and Communication (ICSC 2022) 2022 10.1109/ICSC56524.2022.10009135 78 Gupta A Bhagat M Jain V Blockchain-enabled healthcare monitoring system for early Monkeypox detection J Supercomput 2023 79 14 1 25 10.1007/s11227-023-05288-y 37359326 PMC10118230 79 Gupta P Mittal U Jha T Agarwal M Tiwari A Proceedings of the 2023 2nd Edition of IEEE Delhi Section Flagship Conference (DELCON) 2023 10.1109/DELCON57910.2023.10127329 80 Haque ME Ahmed MR Nila RS Islam S Proceedings of the 2022 25th International Conference on Computer and Information Technology (ICCIT) 2022 10.1109/ICCIT57492.2022.10055870 81 Haque R Sultana A Haque P Proceedings of Congress on Control, Robotics, and Mechatronics: CRM 2023 Smart Innovation, Systems and Technologies 82 Haripriya KP Hannah Inbarani H Proceedings of Congress on Control, Robotics, and Mechatronics: CRM 2023 2024 Smart Innovation, Systems and Technologies 10.1007/978-981-99-5180-2_18 83 Hossen MR Alfaz N Sami A Tanim SA Bin Sarwar T Islam MK Proceedings of the 2023 IEEE International Conference on Omni-Layer Intelligent Systems (COINS) 2023 10.1109/COINS57856.2023.10189311 84 Huong LH Khang NH Quynh L Thang L Canh DM Sang HP A proposed approach for monkeypox classification Int J Adv Comput Sci Appl 2023 14 8 643 651 85 Hussain SM Ghouse S Detection and prediction of monkey pox disease by enhanced convolutional neural network approach Int J Public Health Sci. 2023 12 2 673 681 10.11591/ijphs.v12i2.22310 86 Gupta K Bajaj V Proceedings of the 2023 5th International Conference on Control and Robotics (ICCR) 2023 10.1109/ICCR60000.2023.10444833 87 Gürbüz S Aydin G Proceedings of the 2022 International Conference on Computers and Artificial Intelligence Technologies (CAIT) 2022 10.1109/CAIT56099.2022.10072140 88 Irmak MC Aydin T Yağanoğlu M Proceedings of the 2022 Medical Technologies Congress (TIPTEKNO) 2022 10.1109/TIPTEKNO56568.2022.9960194 89 Trang K Nguyen AH Thao NGM Vuong BQ Ton-That L Proceedings of the 2023 62nd Annual Conference of the Society of Instrument and Control Engineers (SICE) 2023 10.23919/SICE59929.2023.10354166 90 Islam T Hussain, Chowdhury FUH, Islam BMR. Can artificial intelligence detect monkeypox from digital skin images? bioRxiv 10.1101/2022.08.08.503193 91 Jahan N Bajwa G Akilan T Proceedings of the 2023 IEEE Western New York Image and Signal Processing Workshop (WNYISPW) 2023 10.1109/WNYISPW60588.2023.10349384 92 Jaradat AS Al Mamlook RE Almakayeel N Automated monkeypox skin lesion detection using deep learning and transfer learning techniques Int J Environ Res Public Health 2023 20 5 4422 10.3390/ijerph20054422 36901430 PMC10001976 93 Kakulapati V Analysis of monkey pox (mpox) detection using UNETs and VGG16 weights Swaroop A Polkowski Z Correia SD Virdee B Proceedings of Data Analytics and Management: ICDAM 2023 Springer 2023 321 322 Lecture Notes in Networks and Systems 10.1007/978-981-99-6553-3_25 94 Vandana V Kaushal C 2023 10.1109/IC3I59117.2023.10398054 95 Khafaga DS Ibrahim A El-Kenawy EM An Al-Biruni earth radius optimization-based deep convolutional neural network for classifying monkeypox disease Diagnostics (Basel) 2022 12 11 2892 10.3390/diagnostics12112892 36428952 PMC9689640 96 Khan SUR Asif S Bilal O Ali S Deep hybrid model for mpox disease diagnosis from skin lesion images Int J Imaging Syst Technol 2024 34 2 e23044 10.1002/ima.23044 97 Kottath AV Malarvel M 2023 10.1109/ICAEECI58247.2023.10370981 98 Krishnan T Selvakumar K Vairachilai S Monkeypox detection through watershed segmentation and appending 2D CNN based auto encoder monkeypox detection through CNN-auto encoder Int J Recent Innov Trends Comput Commun 2023 11 9s 598 606 10.17762/ijritcc.v11i9s.7472 99 Krishnan T Selvakumar K Vairachilai S Multi-task learning for monkeypox skin lesion segmentation and classification using CNN and ROOTSIFT J Theor Appl Inf Technol 2024 101 1 339 349 100 Krishnan VG Liya BS Lakshmi SV Sathyamoorthy K Ganesan S Monkeypox detection using hyper-parameter tuned based transferable CNN model Int J Exp Res Rev 2023 33 18 29 10.52756/ijerr.2023.v33spl.003 101 Kumar A An XNOR-ResNet and spatial pyramid pooling-based YOLO v3-tiny algorithm for monkeypox and similar skin disease detection Imaging Sci J 2023 71 1 50 65 10.1080/13682199.2023.2175423 102 Kumar V Analysis of CNN features with multiple machine learning classifiers in diagnosis of monkeypox from digital skin images. medRxiv 2022 10.1101/2022.09.11.22278797 103 Kundu D Rahman MM Rahman A Federated deep learning for monkeypox disease detection on GAN-augmented dataset IEEE Access 2024 12 32819 32829 10.1109/ACCESS.2024.3370838 104 Kundu D Siddiqi UR Rahman MM 2022 10.1109/ICCIT57492.2022.10054797 105 Kundu NK Karim M Kobir S Farid DM 2023 10.1109/ICCIT60459.2023.10441278 106 Lakshmi M Das R Classification of monkeypox images using LIME-enabled investigation of deep convolutional neural network Diagnostics (Basel) 2023 13 9 1639 10.3390/diagnostics13091639 37175030 PMC10178151 107 Liu R. 2023 https://www.spiedigitallibrary.org/conference-proceedings-of-spie/12611/126115O/Convolutional-Siamese-network-based-few-shot-learning-for-monkeypox-detection/10.1117/12.2669964.short 108 Liu W. 2023 https://www.spiedigitallibrary.org/conference-proceedings-of-spie/12611/126110U/Implementation-of-detection-of-skin-lesions-in-monkeypox-based-on/10.1117/12.2669408.short 109 Madhu HS Rallapalli S Thatikonda R 2023 10.1109/EASCT59475.2023.10392701 110 Magboo VPC Magboo MSA 2023 10.1109/ITMS59786.2023.10317649 111 Meena G Mohbey KK Kumar S Monkeypox recognition and prediction from visuals using deep transfer learning-based neural networks Multimedia Tools Appl 2024 83 71695 71719 10.1007/s11042-024-18437-z 112 Muduli D Naidu AVSC Durga KV Rahul K Kumar MJ Sharma SK 2023 10.1109/AESPC59761.2023.10390185 113 Muñoz-Saavedra L Escobar-Linero E Civit-Masot J Luna-Perejón F Civit A Domínguez-Morales M A robust ensemble of convolutional neural networks for the detection of monkeypox disease from skin images Sensors (Basel) 2023 23 16 7134 10.3390/s23167134 37631672 PMC10459252 114 Nayak T Chadaga K Sampathila N Detection of monkeypox from skin lesion images using deep learning networks and explainable artificial intelligence Applied Mathematics in Science and Engineering 2023 31 1 10.1080/27690911.2023.2225698 115 Nayak T Chadaga K Sampathila N Deep learning based detection of monkeypox virus using skin lesion images Med Nov Technol Devices 2023 18 100243 10.1016/j.medntd.2023.100243 37293134 PMC10236906 116 Nazmee N Ali MS Mahmud S Alam K Chakrabarty A Fahim-Ul-Islam M 2023 10.1109/ICCIT60459.2023.10441041 117 Ozaltin O Yeniay O Detection of monkeypox disease from skin lesion images using Mobilenetv2 architecture Communications 2023 72 2 482 499 10.31801/cfsuasmas.1202806 118 Pabbi V Khullar V Angurala M 2023 https://www.proceedings.com/68812.html 119 Pal M Mahal A Mohapatra RK Deep and transfer learning approaches for automated early detection of monkeypox (mpox) alongside other similar skin lesions and their classification ACS Omega 2023 8 35 31747 31757 10.1021/acsomega.3c02784 37692219 PMC10483519 120 Pal S Mishra AK 2023 10.1109/CSET58993.2023.10346841 121 Pasha MS Poornima A Athapuram D Skin image analysis for monkeypox diagnosis: multi-layer CNN model advancements J Cardiovasc Dis Res 2023 14 2 2381 2393 122 Pramanik A Chowdhury F Sultana S Rahman MM Bijoy MHI Rahman MS 2023 10.1109/I2CT57861.2023.10126223 123 Pramanik R Banerjee B Efimenko G Kaplun D Sarkar R Monkeypox detection from skin lesion images using an amalgamation of CNN models aided with Beta function-based normalization scheme PLoS One 2023 18 4 e0281815 10.1371/journal.pone.0281815 37027356 PMC10081766 124 Prasher S Nelson L Gomathi S 2023 10.1109/WCONF58270.2023.10234989 125 Raha AD Gain M Debnath R Attention to monkeypox: an interpretable monkeypox detection technique using attention mechanism IEEE Access 2024 12 51942 51965 10.1109/ACCESS.2024.3385099 126 Rai S Joshi RC Dutta MK 2023 10.1109/InCACCT57535.2023.10141823 127 Rao ML Mahesh AV Manikanth MNVJ Sailaja J Bhargavi KN Monkeypox detection and classification using multi-layer convolutional neural network from skin images J Eng Appl Sci (Asian Res Publ Netw) 2023 18 21 2364 2379 10.59018/1123288 128 Ren GY Monkeypox disease detection with pretrained deep learning models Inf Technol Control 2023 52 2 288 296 10.5755/j01.itc.52.2.32803 129 Sahin VH Oztel I Yolcu Oztel G Human monkeypox classification from skin lesion images with deep pre-trained network using mobile application J Med Syst 2022 46 11 79 10.1007/s10916-022-01863-7 36210365 PMC9548428 130 Sathwik AS Naseeba B Kiran JC Lokesh K Ch VSD Challa NP Early detection of monkeypox skin disease using patch based DL model and transfer learning techniques EAI Endorsed Trans Pervasive Health Technol 2023 9 10.4108/eetpht.9.4313 131 Shah A 2022 10.1109/IBSSC56953.2022.10037374 132 Sharma A Gupta S Anand V 2023 10.1109/ICAECT57570.2023.10118296 133 Sharma K Kumar V Mittal M 2023 10.1109/ISCON57294.2023.10112085 134 Sharma N Mohanty SN Mahato S Pattanaik CR A novel dataset and local interpretable model-agnostic explanations (LIME) for monkeypox prediction Intelligent Decision Technologies-Netherlands. 2023 17 4 1297 1308 10.3233/IDT-230222 135 Singh U Songare LS 2022 10.1109/ICACRS55517.2022.10029125 136 Sorayaie Azar A Naemi A Babaei Rikan S Bagherzadeh Mohasefi J Pirnejad H Wiil UK Monkeypox detection using deep neural networks BMC Infect Dis 2023 23 1 438 10.1186/s12879-023-08408-4 37370031 PMC10304329 137 Supanich W Kulkarineetham S Tamboonlertchai W Suato T 2023 10.1109/RAEEUCCI57140.2023.10134059 138 Surati S Trivedi H Shrimali B Bhatt C Travieso-González CM An enhanced diagnosis of monkeypox disease using deep learning and a novel attention model senet on diversified dataset Multimodal Technol Interact 2023 7 8 75 10.3390/mti7080075 139 Taruno PEN Nugraha GS Dwiyansaputra R Bimantoro F 2023 10.1051/e3sconf/202346502031 140 Tiwari S Maheshwari P 2023 10.1109/ICCIKE58312.2023.10131756 141 Torky M Bakheit A Bakry M Hassanien AE Deep learning model for recognizing monkey pox based on dense net-121 algorithm. medRxiv 10.1101/2022.12.20.22283747 142 Ural AB A computer-aided feasibility implementation to detect monkeypox from digital skin images with using deep artificial intelligence methods TS Trait Signal 2023 40 1 383 388 10.18280/ts.400139 143 Uysal F Detection of monkeypox disease from human skin images with a hybrid deep learning model Diagnostics (Basel) 2023 13 10 1772 10.3390/diagnostics13101772 37238256 PMC10217161 144 Uzun Ozsahin D Mustapha MT Uzun B Duwa B Ozsahin I Computer-aided detection and classification of monkeypox and chickenpox lesion in human subjects using deep learning framework Diagnostics (Basel) 2023 13 2 292 10.3390/diagnostics13020292 36673101 PMC9858137 145 Vajpayee H Arora C Voleti R Chaudhary A Raj G Agrawal AP 2023 10.1109/Confluence56041.2023.10048840 146 Yadav S Qidwai T Machine learning-based monkeypox virus image prognosis with feature selection and advanced statistical loss function Med Microecol 2024 19 100098 10.1016/j.medmic.2024.100098 147 Yasmin F Hassan MM Hasan M PoxNet22: a fine-tuned model for the classification of monkeypox disease using transfer learning IEEE Access 2023 11 24053 24076 10.1109/ACCESS.2023.3253868 148 Zi S RICAI '22: Proceedings of the 2022 4th International Conference on Robotics, Intelligent Control and Artificial Intelligence 2023 10.1145/3584376.3584585 149 Danpakdee N Songpan W Classification model for skin lesion image Kim K Joukov N Information Science and Applications 2017: ICISA 2017 Springer 2017 Lecture Notes in Electrical Engineering 150 Bajwa UI Alam S Ul Haq N Ratyal NI Anwar MW Skin disease classification using neural network Curr Med Imaging 2020 16 6 711 719 10.2174/1573405615666190422152926 32723243 151 Hestiningsih I Thohari ANA Kamarudin ND Mobile skin disease classification using MobileNetV2 and NASNetMobile Int J Adv Sci Eng Inf Technol 2023 13 4 1472 1479 10.18517/ijaseit.13.4.18290 152 Chaurasia V Pal S Skin diseases prediction: binary classification machine learning and multi model ensemble techniques Res J Pharm Technol 2019 12 8 3829 3832 10.5958/0974-360X.2019.00656.5 153 Rimi TA Sultana N Foysal MFA 2020 10.1109/ICICCS48265.2020.9120925 154 Andryani NAC Juwono FH Sianturi PJ Artificial intelligence approach for automatic multiclass skin diseases identification Journal of Engineering Science and Technology 2023 18 99 111 155 Aziz MA Pujiono P Arief Soeleman M Rosidin S 2023 https://ieeexplore.ieee.org/xpl/conhome/10294330/proceeding 156 Oraño JFV Padao FRF Malangsa RD Novel & Intelligent Digital Systems: Proceedings of the 2nd International Conference (NiDS 2022) 2023 Lecture Notes in Networks and Systems 157 Eze MC Vafaei LE Eze CT Tursoy T Ozsahin DU Mustapha MT Development of a novel multi-modal contextual fusion model for early detection of varicella zoster virus skin lesions in human subjects Processes (Basel) 2023 11 8 10.3390/pr11082268 158 Krammer S Li Y Jakob N Deep learning-based classification of dermatological lesions given a limited amount of labelled data J Eur Acad Dermatol Venereol 2022 36 12 2516 2524 10.1111/jdv.18460 35876737 159 Mejia Lara JV Arias Velasquez RM Low-cost image analysis with convolutional neural network for herpes zoster Biomed Signal Process Control 2022 71 103250 10.1016/j.bspc.2021.103250 160 Negi Y Marimuthu P Rauniyar NR Patil US Shaheen H Proceedings of Fifth International Conference on Computer and Communication Technologies (IC3T 2023) 2024 Lecture Notes in Networks and Systems 10.1007/978-981-99-9707-7_34 161 Ali SN Ahmed T Paul J Monkeypox skin lesion detection using deep learning models: a feasibility study. arXiv 10.48550/arXiv.2207.03342 162 Bala D Hossain MS Monkeypox Skin Images Dataset (MSID). Mendeley Data 2023 https://data.mendeley.com/datasets/r9bfpnvyxr/6 163 Campana MG Colussi M Delmastro F Mascetti S Pagani E Mpox close skin images. Zenodo 2023 https://zenodo.org/records/7948350 164 Shumway NK Skin diseases of the genitals and perineum Soutor C Hordinsky MK Clinical Dermatology: Diagnosis and Management of Common Disorders McGraw-Hill Education 2022 165 DermNet 2002 https://dermnetnz.org/topics/genital-skin-problems 166 Stamm AW Kobashi KC Stefanovic KB Urologic dermatology: a review Curr Urol Rep 2017 18 8 62 10.1007/s11934-017-0712-9 28667573 167 Shobajo M Abdulkadir S Kraus CN Shiu J Anogenital skin of color images are underrepresented in dermatology, gynecology, and urology educational textbooks Int J Womens Dermatol 2023 9 3 e090 10.1097/JW9.0000000000000090 37424795 PMC10325740 168 International Agency for Research on Cancer https://screening.iarc.fr/cervicalimagebank.php 169 Asif S Zhao M Li YF Tang FX Khan SUR Zhu YS AI-based approaches for the diagnosis of mpox: challenges and future prospects Arch Comput Methods Eng 2024 10.1007/s11831-024-10091-w 170 Vega C Schneider R Satagopam V Analysis: flawed datasets of monkeypox skin images J Med Syst 2023 47 1 37 10.1007/s10916-023-01928-1 36933065 PMC10024024 171 Collins GS Moons KGM Dhiman P TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods BMJ 2024 385 e078378 10.1136/bmj-2023-078378 38626948 PMC11019967 172 Finnane A Curiel-Lewandrowski C Wimberley G International Society of Digital Imaging of the Skin (ISDIS) for the International Skin Imaging Collaboration (ISIC) Proposed technical guidelines for the acquisition of clinical images of skin-related conditions JAMA Dermatol 2017 153 5 453 457 10.1001/jamadermatol.2016.6214 28241182 173 Dagan N Devons-Sberro S Paz Z Evaluation of AI solutions in health care organizations—the OPTICA tool NEJM AI 2024 10.1056/AIcs2300269 174 Widner K Virmani S Krause J Lessons learned from translating AI from development to deployment in healthcare Nat Med 2023 29 6 1304 1306 10.1038/s41591-023-02293-9 37248297 175 Larrazabal AJ Nieto N Peterson V Milone DH Ferrante E Gender imbalance in medical imaging datasets produces biased classifiers for computer-aided diagnosis Proc Natl Acad Sci U S A 2020 117 23 12592 12594 10.1073/pnas.1919012117 32457147 PMC7293650 176 Kelly CJ Karthikesalingam A Suleyman M Corrado G King D Key challenges for delivering clinical impact with artificial intelligence BMC Med 2019 17 1 195 10.1186/s12916-019-1426-2 31665002 PMC6821018 177 Callahan A McElfresh D Banda JM Standing on FURM ground: a framework for evaluating fair, useful, and reliable AI models in health care systems NEJM Catal 2024 10.1056/CAT.24.0131 178 Liu X Cruz Rivera S Moher D Calvert MJ Denniston AK SPIRIT-AI and CONSORT-AI Working Group Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension Nat Med 2020 26 9 1364 1374 10.1038/s41591-020-1034-x 32908283 PMC7598943 179 Ly S Reyes-Hadsall S Drake L Public perceptions, factors, and incentives influencing patient willingness to share clinical images for artificial intelligence-based healthcare tools Dermatol Ther (Heidelb) 2023 13 11 2895 2902 10.1007/s13555-023-01031-w 37737327 PMC10613161 180 Soe NN Latt PM King A What do people want from an AI-assisted screening app for sexually transmitted infection-related anogenital lesions: a discrete choice experiment Patient 2025 18 2 141 143 10.1007/s40271-024-00720-8 39485672 PMC11832619 181 Abraham E Chow EPF Fairley CK eSexualHealth: Preferences to use technology to promote sexual health among men who have sex with men and trans and gender diverse people Front Public Health 2023 10 1064408 10.3389/fpubh.2022.1064408 36711397 PMC9877518 182 Latt PM Soe NN Fairley CK Machine learning for personalized risk assessment of HIV, syphilis, gonorrhoea and chlamydia: a systematic review and meta-analysis Int J Infect Dis 2025 157 107922 10.1016/j.ijid.2025.107922 40339784 PMC12181084 183 Jakob L Steeb T Fiocco Z Patient perception of mobile phone apps for the care and prevention of sexually transmitted diseases: cross-sectional study JMIR Mhealth Uhealth 2020 8 11 e16517 10.2196/16517 33170133 PMC7685917 184 Gronsbell J Hong C Nie L Lu Y Tian L Exact inference for the random-effect model for meta-analyses with rare events Stat Med 2020 39 3 252 264 10.1002/sim.8396 31820458 PMC7704100 Supplement 1. eTable 1. eTable 2 eTable 3. eTable 4. eTable 5. eFigure 1. eFigure 2. eReferences Supplement 2. Data Sharing Statement ",
  "metadata": {
    "Title of this paper": "Exact inference for the random-effect model for meta-analyses with rare events",
    "Journal it was published in:": "JAMA Network Open",
    "URL": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12495501/"
  }
}